Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor

被引：0
|
作者：
Kano, Yasuhiro [1 ]
Kato, Miyuki [2 ]
机构：
[1] Tokyo Metropolitan Tama Med Ctr, Dept Gen Internal Med, Tokyo, Japan
[2] Tokyo Metropolitan Tama Med Ctr, Dept Dermatol, Tokyo, Japan
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2022年 / 194卷 / 20期
关键词：
D O I：
10.1503/cmaj.211933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E705 / E705
页数：1
相关论文
共 50 条
  • [41] The effect of dipeptidyl peptidase-4 inhibitor on incidence and clinical course in bullous pemphigoid patients in a tertiary medical center
    Hsu, Yu-Han Alice
    Yang, Ting-Ting
    Huang, Shu-Mei
    Lan, Cheng-Che Eric
    [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (10): : 1038 - 1044
  • [42] Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea
    Lee, Hemin
    Chung, Hye Jin
    Pawar, Ajinkya
    Patorno, Elisabetta
    Kim, Dae Hyun
    [J]. JAMA DERMATOLOGY, 2020, 156 (10) : 1107 - 1114
  • [43] Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population
    Plaquevent, Marthe
    Tetart, Florence
    Fardet, Laurence
    Ingen-Housz-Oro, Saskia
    Valeyrie-Allanore, Laurence
    Bernard, Philippe
    Hebert, Vivien
    Roussel, Aude
    Avenel-Audran, Martine
    Chaby, Guillaume
    D'Incan, Michel
    Ferrier-Le-Bouedec, Marie-Christine
    Duvert-Lehembre, Sophie
    Picard-Dahan, Catherine
    Jeudy, Geraldine
    Collet, Evelyne
    Labeille, Bruno
    Morice, Cecile
    Richard, Marie-Aleth
    Bourgault-Villada, Isabelle
    Litrowski, Noemie
    Bara, Corina
    Mahe, Emmanuel
    Prost-Squarcioni, Catherine
    Alexandre, Marina
    Quereux, Gaelle
    Bernier, Claire
    Soria, Angele
    Thomas-Beaulieu, Domitille
    Pauwels, Christine
    Dereure, Olivier
    Benichou, Jacques
    Joly, Pascal
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (04) : 835 - 841
  • [44] Dipeptidyl Peptidase-4 Inhibitor-Related Bullous Pemphigoid: Clinical, Laboratory, and Histological Features, and Possible Pathogenesis
    Hung, Chih-Tsung
    Chang, Yung-Lung
    Wang, Wei-Ming
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [45] Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
    Thewjitcharoen, Yotsapon
    Wanothayaroj, Ekgaluck
    Thammawiwat, Chattip
    Porramatikul, Sriurai
    Vorayingyong, Chuleekorn
    Nakasatien, Soontaree
    Krittiyawong, Sirinate
    Chanprapaph, Kumutnart
    Himathongkam, Thep
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [46] Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: evaluation of clinical course and treatment response
    Tzanani, Ido
    Tzachy-Suissa, Inbar
    Barzilai, Aviv
    Pavlotsky, Felix
    Lyakhovitsky, Anna
    Baum, Sharon
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (08) : 873 - 880
  • [47] Commentary on 'Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors'
    Fania, L.
    Di Zenzo, G.
    Mazzanti, C.
    Abeni, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : E439 - E440
  • [48] Clinical and immunological characterization of 14 cases of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a single-centre study
    Hayashi, M.
    Tsunoda, T.
    Sato, F.
    Yaguchi, Y.
    Igarashi, M.
    Izumi, K.
    Nishie, W.
    Ishii, N.
    Okamura, K.
    Suzuki, T.
    Hashimoto, T.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (03) : 806 - 807
  • [49] Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors
    Fania, Luca
    Salemme, Adele
    Provini, Alessia
    Pagnanelli, Gianluca
    Collina, Maria Chiara
    Abeni, Damiano
    Didona, Biagio
    Di Zenzo, Giovanni
    Mazzanti, Cinzia
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) : 592 - 595
  • [50] Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid
    Kokubu, Hiraku
    Takahashi, Toshifumi
    Kabuto, Miho
    Kouzaki, Hideaki
    Fujimoto, Noriki
    [J]. EXPERIMENTAL DERMATOLOGY, 2023, 32 (09) : 1569 - 1574
12345